Shorter sampling interval in pilot - Good idea? [Design Issues]

posted by nobody – 2018-02-27 20:02 (3041 d 15:14 ago) – Posting: # 18472
Views: 5,596

Hy!

Have a drug with "normal" half-life of some hours in the mean, but considerable variability (BOTH target params). So pilot will be huuuugh and fully replicate (planned: EU submission).

Sponsor wants to make a little cheaper by having only 24 h sampling in the pilot, but considerably longer in the pivotal trial.

Good idea? Regarding sample size estimation for the pivotal (including adjusted acceptance range for Cmax, but standard acceptance range for AUC...).

Any thoughts or numbers? :-)

Οὐδείς

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
376 visitors (0 registered, 376 guests [including 15 identified bots]).
Forum time: 12:16 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5